long acting gh

According to Key Opinion Leaders (KOLs) interviewed by GlobalData, patient compliance with daily growth hormone drugs has been a long-standing issue in the GHD treatment landscape, and it remains the greatest unmet need. As a consequence, pharmaceutical companies are focusing heavily on...